Yuting Pan

4PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 19, 2025
Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid Tumors.

Yuting Pan, Xin Zhang, Chunmeng Wang

|Nov 29, 2023
Long-term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine-plus-camrelizumab epi-immunotherapy and treatment cessation.

Chunmeng Wang, Yuting Pan, Yang Liu

|Mar 28, 2022
Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score.

Yuting Pan, Hanyan Si, Ru Jia

|Jul 09, 2021
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.

Shiyun Chen, Miaomiao Gou, Huan Yan

Pageof 1

Frequent Collaborators

2 joint publications

Shiyun Chen

2 joint publications

Miaomiao Gou

2 joint publications

Huan Yan

2 joint publications

Mengjiao Fan